[ad_1]
Anvisa (National Health Surveillance Agency) confirmed on Friday (27) the receipt of data for the approval of the Johnson & Johnson vaccine against covid-19.
The agency now has 20 days to review the documents and approve or disapprove the authenticity of the immunizer against respiratory disease caused by the new coronavirus.
Read more: Government will distribute vaccine after approval, says Bolsonaro
“With the opening of the process, the laboratory also sent the first package referring to product quality data. In continuous shipment, the laboratories must present the quality and effectiveness / safety data packages ”, says Anvisa, in a note.
In the document, Anvisa highlights that the presentation “is not yet the application for registration of the vaccine. The shipment is an anticipated shipment of data already ready and consolidated that will be necessary for the future application of registry ”, explains the agency.
Johnson & Johnson is the fourth pharmacist to submit data on the development of vaccine studies. The Pfizer, AstraZeneca and Sinovac laboratories have also submitted their reports to Anvisa.
